not accurately reflect what constitutes satisfying sex in this population, yielding falsely low scores.
Representation of Women as Authors, Reviewers, Editors in Chief, and Editorial Board Members at 6 General Medical Journals in 2010 and 2011
Although more women continue to enter the medical profession, disparities between the sexes persist in academic medicine. This gender gap has implications for peer recognition and academic advancement. In 2006, Jagsi and colleagues 1 reported that the proportion of women as the first and the senior (last listed) physician authors of original research significantly increased between 1970 and 2004. Women, however, still represented a minority of the authors of original research and editorials in 6 prominent medical journals. A related study 2 found a substantial increase in the representation of women on editorial boards and as editors in chief of prominent journals. Using data from January 2010 to December 2011, we determined the proportion of women who were authors of original research or editorials, reviewers, editors in chief, or editorial board members at 6 general medical journals: To interpret these data requires looking at medical schools, because authors, editorial board members, and peer reviewers come from the upper rungs of the academic ladder. What is the composition of the pool from which the journals draw? That depends on the level of seniority. In the United States, approximately half of all medical students are now women, but men still outnumber women among faculty members, particularly at the top. (It may be different in the United Kingdom, which might explain the BMJ advantage.) In 2004, only 19% of associate and full professors on the clinical faculties of US medical schools were women, and women composed 38% of assistant professors. 3 Calls for journals to invite more women to write nonresearch articles are all to the good 4 because they give women more visibility, but until women move up the academic ladder, they will still be underrepresented as authors of research articles. The problem is not so much at the journals as it is at the medical schools.
Have women advanced as fast as they should given the fact that they began to enter academic medicine in large numbers in the 1970s? According to Jagsi et al, 2 women made up 14% of all US medical students in 1972 and the same percentage of represented at the lower rungs of the academic ladder, then they stall and become associate or full professors, if at all, at an older age than their male counterparts. Why the lag? One factor is probably the reward system in academic medicine. As Jagsi et al 2(p281) point out, "advancement is largely driven by peer-reviewed original research," particularly that published in prestigious journals. Publication is the coin of the realm. I believe men are more likely than women to devote themselves single-mindedly to research, partly because women are disproportionately tapped for various academic citizenship duties (every committee needs at least 1 woman), and because the child-bearing years coincide with the time of applying for first research grants. Research grants impose a fairly rigid schedule that can conflict with the flexibility needed in those early years. Greater flexibility in the timing of first research grants would help women pursue research careers. Young male physicians are also beginning to value flexibility when their children are young because, unlike their older male colleagues, very few of them have spouses that are housewives; however, the difficulties are not equal. A final possible explanation for the slow advancement of women-one that will surprise very few women-is good old-fashioned sexism. This is demonstrated by Lawrence Summers, PhD, the former president of Harvard University, who said the most likely explanation for the relatively low numbers of women scientists is that, compared with men, their brains just aren't up to the job. 6 (Summers did not explain how their brains evolved fast enough to account for the recent dramatic influx of women in science.) Despite the difficulties, women are pressing hard against the glass ceiling, and it will inevitably shatter. But progress is too slow. One reform that should be instituted-not just because it would further equality between men and women, but because it would be of great benefit to academic medicine-is to change the reward system. Anecdotal evidence suggests that women do more than their share of teaching and mentoring. Those activities should be a basis for promotion, at least as much as publications are. The primary mission of medical schools is, after all, to educate the next generation of physicians. Clinical research and medical practice are important parts of that mission, but secondary. Faculty researchers often do little or no teaching, yet advance rapidly on the basis of their publications, while excellent teachers languish at the lower rungs of the academic ladder. Too many men (and women) are doing pedestrian research simply to be promoted. Doubtless, one reason institutions reward research over teaching is that research grants bring in more money than does tuition. Yet, medical schools have an obligation to do better by their students and the physicians who teach them. In recent years, there has been a certain amount of hand wringing about the reward system, with some increased recognition of teaching, but there is still nothing close to parity. This is not a matter of suggesting that standards for promotion be lowered so that women have an easier time getting to the top. On the contrary, I am recommending that the top be redefined. I do not advocate a lowered glass ceiling, but rather, placing the ceiling over a different edifice. Research productivity should no longer be considered the primary measure of academic success. If teaching and mentoring are rewarded commensurately with research, women will do very well. In fact, men might well have to work harder than they are now to catch up with women in these areas. In any case, I have no doubt that physicians would be better educated and that the medical literature would be less voluminous but of higher quality. And the glass ceiling would shatter that much faster.
Marcia Angell, MD

COMMENT & RESPONSE
Optimizing the Impact of Drugs on Symptom Burden in Older People With Multimorbidity at the End of Life
To the Editor We commend Chaudhry et al 1 on their excellent article that reported high prevalence of symptoms that negatively affect functioning and quality of life in a cohort of older community-dwelling people with multimorbidity and a life expectancy of less than 1 year. In older people, mulitimorbidity often coexists with polypharmacy, commonly defined as the use of 5 or more drugs. In her Invited Commentary, Ritchie 2 highlights that pharmacological treatment of 1 symptom may exacerbate another or a coexisting condition, which may in part explain the increase in symptoms in this population.
To minimize drug-related symptoms in older people at the end of life, pharmacological treatments should be prioritized and rationalized. Symptomatic relief should take preference over preventive treatments, and drug therapies deemed no longer necessary should be stopped to minimize cumulative drugrelated adverse effects. For instance, among patients in their
